Diltiazem Hydrochloride Patent Expiration
Diltiazem Hydrochloride was first introduced by Bausch Health Us Llc
Diltiazem Hydrochloride Patents
Given below is the list of patents protecting Diltiazem Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Cardizem La | US6923984 | Cushioning wax beads for making solid shaped articles |
Feb 25, 2021
(Expired) | Bausch |
Cardizem La | US7108866 | Chronotherapeutic diltiazem formulations and the administration thereof |
Dec 17, 2019
(Expired) | Bausch |
Cardizem La | US5529791 | Extended release form of diltiazem |
Jun 25, 2013
(Expired) | Bausch |
Diltiazem Hydrochloride | US5529791 | Extended release form of diltiazem |
Jun 25, 2013
(Expired) | Biovail |
Tiazac | US5529791 | Extended release form of diltiazem |
Jun 25, 2013
(Expired) | Bausch |
Cardizem Cd | US5439689 | Diltiazem formulation |
Aug 08, 2012
(Expired) | Bausch |
Diltiazem Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Diltiazem Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Diltiazem Hydrochloride. The first generic version for Diltiazem Hydrochloride was by Rising Pharma Holding Inc and was approved on Nov 5, 1992. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Oct 18, 2024.
Given below is the list of companies who have filed for Diltiazem Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
180MG | capsule, extended release | Prescription | ORAL | AB2 | Apr 28, 2020 |
240MG | capsule, extended release | Prescription | ORAL | AB2 | Apr 28, 2020 |
120MG | capsule, extended release | Prescription | ORAL | AB2 | Apr 28, 2020 |
2. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 1 generic for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
360MG | capsule, extended release | Prescription | ORAL | AB3 | Dec 7, 2012 |
Manufacturing Plant Locations New
Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
3. ACTAVIS LABS FL INC
Actavis Laboratories Fl Inc has filed for 6 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
120MG | tablet, extended release | Prescription | ORAL | AB | Mar 15, 2010 |
240MG | tablet, extended release | Prescription | ORAL | AB | Mar 15, 2010 |
180MG | tablet, extended release | Prescription | ORAL | AB | Mar 15, 2010 |
300MG | tablet, extended release | Prescription | ORAL | AB | Mar 15, 2010 |
360MG | tablet, extended release | Prescription | ORAL | AB | Mar 15, 2010 |
420MG | tablet, extended release | Prescription | ORAL | AB | Mar 15, 2010 |
4. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
120MG | capsule, extended release | Prescription | ORAL | AB2 | Oct 18, 2024 |
240MG | capsule, extended release | Prescription | ORAL | AB2 | Oct 18, 2024 |
180MG | capsule, extended release | Prescription | ORAL | AB2 | Oct 18, 2024 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
Country | City | Firm Name | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|
5. AMTA
Amta Labs Ltd has filed for 6 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Amta.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
420MG | tablet, extended release | Prescription | ORAL | AB | Mar 7, 2023 |
120MG | tablet, extended release | Prescription | ORAL | AB | Mar 7, 2023 |
180MG | tablet, extended release | Prescription | ORAL | AB | Mar 7, 2023 |
240MG | tablet, extended release | Prescription | ORAL | AB | Mar 7, 2023 |
300MG | tablet, extended release | Prescription | ORAL | AB | Mar 7, 2023 |
360MG | tablet, extended release | Prescription | ORAL | AB | Mar 7, 2023 |
Manufacturing Plant Locations New
Amta's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Amta as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
6. APOTEX
Apotex Inc has filed for 5 different strengths of generic version for Diltiazem Hydrochloride. All of these versions come by the name DILTZAC. Given below are the details of the strengths of this generic introduced by Apotex.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
240MG | capsule, extended release | Discontinued | ORAL | N/A | Feb 1, 2006 |
180MG | capsule, extended release | Discontinued | ORAL | N/A | Feb 1, 2006 |
120MG | capsule, extended release | Discontinued | ORAL | N/A | Feb 1, 2006 |
300MG | capsule, extended release | Discontinued | ORAL | N/A | Feb 1, 2006 |
360MG | capsule, extended release | Discontinued | ORAL | N/A | Feb 1, 2006 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
Country | City | Firm Name | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||
Canada |
| |||||||||||||
India |
|
7. APOTHECON
Apothecon Inc Div Bristol Myers Squibb has filed for 4 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Apothecon.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
30MG | tablet | Discontinued | ORAL | N/A | Mar 31, 1993 |
60MG | tablet | Discontinued | ORAL | N/A | Mar 31, 1993 |
90MG | tablet | Discontinued | ORAL | N/A | Mar 31, 1993 |
120MG | tablet | Discontinued | ORAL | N/A | Mar 31, 1993 |
Manufacturing Plant Locations New
Apothecon's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Apothecon as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
8. BIOVAIL
Biovail Laboratories Inc has filed for 3 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Biovail.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
90MG | capsule, extended release | Discontinued | ORAL | N/A | Sep 15, 1999 |
60MG | capsule, extended release | Discontinued | ORAL | N/A | Sep 15, 1999 |
120MG | capsule, extended release | Discontinued | ORAL | N/A | Sep 15, 1999 |
Manufacturing Plant Locations New
Biovail's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Biovail as present at those locations.
Country | City | Firm Name | ||||||
---|---|---|---|---|---|---|---|---|
United States |
|
9. CHARTWELL MOLECULES
Chartwell Molecules Llc has filed for 4 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Molecules.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
120MG | tablet | Discontinued | ORAL | N/A | Nov 5, 1992 |
90MG | tablet | Discontinued | ORAL | N/A | Nov 5, 1992 |
60MG | tablet | Discontinued | ORAL | N/A | Nov 5, 1992 |
30MG | tablet | Discontinued | ORAL | N/A | Nov 5, 1992 |
10. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG/ML | injectable | Discontinued | INJECTION | N/A | Aug 26, 1997 |
11. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 3 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
60MG | capsule, extended release | Prescription | ORAL | AB1 | May 5, 2022 |
90MG | capsule, extended release | Prescription | ORAL | AB1 | May 5, 2022 |
120MG | capsule, extended release | Prescription | ORAL | AB1 | May 5, 2022 |
12. EDENBRIDGE PHARMS
Edenbridge Pharmaceuticals Llc has filed for 4 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Edenbridge Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
30MG | tablet | Discontinued | ORAL | N/A | Nov 18, 2019 |
90MG | tablet | Discontinued | ORAL | N/A | Nov 18, 2019 |
120MG | tablet | Discontinued | ORAL | N/A | Nov 18, 2019 |
60MG | tablet | Discontinued | ORAL | N/A | Nov 18, 2019 |
13. ENDO OPERATIONS
Endo Operations Ltd has filed for 5 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
300MG | capsule, extended release | Prescription | ORAL | AB3 | Dec 20, 1999 |
120MG | capsule, extended release | Prescription | ORAL | AB3 | Dec 20, 1999 |
180MG | capsule, extended release | Prescription | ORAL | AB3 | Dec 20, 1999 |
240MG | capsule, extended release | Prescription | ORAL | AB3 | Dec 20, 1999 |
360MG | capsule, extended release | Discontinued | ORAL | N/A | May 30, 2018 |
14. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG/ML | injectable | Prescription | INJECTION | AP | Mar 29, 2023 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
Country | City | Firm Name | ||||||
---|---|---|---|---|---|---|---|---|
India |
|
15. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
60MG | capsule, extended release | Prescription | ORAL | AB1 | Mar 22, 2021 |
90MG | capsule, extended release | Prescription | ORAL | AB1 | Mar 22, 2021 |
120MG | capsule, extended release | Prescription | ORAL | AB1 | Mar 22, 2021 |
16. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG/ML | injectable | Prescription | INJECTION | AP | Dec 17, 2008 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
Portugal |
| |||||||||
Jordan |
|
17. HIKMA FARMACEUTICA
Hikma Farmaceutica Portugal Sa has filed for 1 generic for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma Farmaceutica.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG/ML | injectable | Discontinued | INJECTION | N/A | Aug 9, 2012 |
Manufacturing Plant Locations New
Hikma Farmaceutica's manufacturing plants are situated in 1 country - Portugal. Given below are the details of these plant locations as well as the firm names of Hikma Farmaceutica as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
Portugal |
|
18. HOSPIRA
Hospira Inc has filed for 2 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Hospira.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG/ML | injectable | Discontinued | INJECTION | N/A | Feb 16, 2000 |
100MG/VIAL
(reference standard) | injectable | Prescription | INJECTION | N/A | Dec 17, 2002 |
Manufacturing Plant Locations New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
Country | City | Firm Name | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Australia |
| |||||||||||||
United States |
| |||||||||||||
Dominican Republic (the) |
|
19. INTL MEDICATION
International Medication Systems Ltd has filed for 1 generic for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Intl Medication.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG/ML | injectable | Discontinued | INJECTION | N/A | Nov 21, 2001 |
20. IVAX SUB TEVA PHARMS
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
30MG | tablet | Discontinued | ORAL | N/A | Mar 3, 1995 |
120MG | tablet | Discontinued | ORAL | N/A | Mar 3, 1995 |
90MG | tablet | Discontinued | ORAL | N/A | Mar 3, 1995 |
60MG | tablet | Discontinued | ORAL | N/A | Mar 3, 1995 |
21. MYLAN
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
60MG | capsule, extended release | Prescription | ORAL | AB1 | May 2, 1997 |
90MG | capsule, extended release | Prescription | ORAL | AB1 | May 2, 1997 |
120MG
(reference standard) | capsule, extended release | Prescription | ORAL | AB1 | May 2, 1997 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
Country | City | Firm Name | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||
India |
| |||||||||||||||||
Canada |
| |||||||||||||||||
Ireland |
|
22. MYLAN LABS LTD
Mylan Laboratories Ltd has filed for 1 generic for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG/ML | injectable | Discontinued | INJECTION | N/A | Sep 30, 1999 |
23. NESHER PHARMS
Nesher Pharmaceuticals Usa Llc has filed for 6 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Nesher Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
240MG | capsule, extended release | Discontinued | ORAL | N/A | Sep 12, 2006 |
120MG | capsule, extended release | Discontinued | ORAL | N/A | Sep 12, 2006 |
180MG | capsule, extended release | Discontinued | ORAL | N/A | Sep 12, 2006 |
420MG | capsule, extended release | Discontinued | ORAL | N/A | Sep 12, 2006 |
300MG | capsule, extended release | Discontinued | ORAL | N/A | Sep 12, 2006 |
360MG | capsule, extended release | Discontinued | ORAL | N/A | Sep 12, 2006 |
24. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 3 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
120MG | capsule, extended release | Discontinued | ORAL | N/A | Mar 18, 1998 |
240MG | capsule, extended release | Discontinued | ORAL | N/A | Mar 18, 1998 |
180MG | capsule, extended release | Discontinued | ORAL | N/A | Mar 18, 1998 |
25. NOVAST LABS
Novast Laboratories Ltd has filed for 5 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Novast Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
300MG | capsule, extended release | Prescription | ORAL | AB3 | Jun 14, 2019 |
360MG | capsule, extended release | Prescription | ORAL | AB3 | Jun 14, 2019 |
120MG | capsule, extended release | Prescription | ORAL | AB3 | Jun 14, 2019 |
180MG | capsule, extended release | Prescription | ORAL | AB3 | Jun 14, 2019 |
240MG | capsule, extended release | Prescription | ORAL | AB3 | Jun 14, 2019 |
26. RISING
Rising Pharma Holdings Inc has filed for 5 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
90MG | tablet | Discontinued | ORAL | N/A | Nov 5, 1992 |
30MG | tablet | Discontinued | ORAL | N/A | Nov 5, 1992 |
60MG | tablet | Discontinued | ORAL | N/A | Nov 5, 1992 |
120MG | tablet | Discontinued | ORAL | N/A | Nov 5, 1992 |
5MG/ML | injectable | Prescription | INJECTION | AP | Apr 9, 1998 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
Country | City | Firm Name | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||
Mexico |
| |||||||||||||||||||
India |
|
27. SAGENT
Sagent Pharmaceuticals has filed for 1 generic for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Sagent.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG/ML
(reference standard) | injectable | Prescription | INJECTION | AP | Feb 28, 1996 |
Manufacturing Plant Locations New
Sagent's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Sagent as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
28. SANDOZ
Sandoz Inc has filed for 6 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
120MG | capsule, extended release | Prescription | ORAL | AB4 | Sep 28, 2012 |
240MG | capsule, extended release | Prescription | ORAL | AB4 | Sep 28, 2012 |
300MG | capsule, extended release | Prescription | ORAL | AB4 | Sep 28, 2012 |
180MG | capsule, extended release | Prescription | ORAL | AB4 | Sep 28, 2012 |
420MG | capsule, extended release | Prescription | ORAL | AB4 | Sep 28, 2012 |
360MG | capsule, extended release | Prescription | ORAL | AB4 | Sep 28, 2012 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
Austria |
| |||||
United States |
| |||||
Spain |
| |||||
India |
|
29. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 9 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
90MG | tablet | Prescription | ORAL | AB | Sep 23, 2022 |
120MG | tablet, extended release | Prescription | ORAL | AB | Apr 6, 2023 |
60MG | tablet | Prescription | ORAL | AB | Sep 23, 2022 |
30MG | tablet | Prescription | ORAL | AB | Sep 23, 2022 |
420MG | tablet, extended release | Prescription | ORAL | AB | Apr 6, 2023 |
360MG | tablet, extended release | Prescription | ORAL | AB | Apr 6, 2023 |
300MG | tablet, extended release | Prescription | ORAL | AB | Apr 6, 2023 |
240MG | tablet, extended release | Prescription | ORAL | AB | Apr 6, 2023 |
180MG | tablet, extended release | Prescription | ORAL | AB | Apr 6, 2023 |
30. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
120MG | capsule, extended release | Prescription | ORAL | AB3 | Jun 8, 2017 |
180MG | capsule, extended release | Prescription | ORAL | AB3 | Jun 8, 2017 |
240MG | capsule, extended release | Prescription | ORAL | AB3 | Jun 8, 2017 |
300MG | capsule, extended release | Prescription | ORAL | AB3 | Jun 8, 2017 |
360MG | capsule, extended release | Prescription | ORAL | AB3 | Jun 8, 2017 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
Country | City | Firm Name | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||||||||||||
India |
|
31. TEVA
Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
60MG | tablet | Prescription | ORAL | AB | May 31, 1995 |
120MG | tablet | Prescription | ORAL | AB | May 31, 1995 |
90MG | tablet | Prescription | ORAL | AB | May 31, 1995 |
30MG | tablet | Prescription | ORAL | AB | May 31, 1995 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
India |
| |||||||||
Canada |
| |||||||||
Czech Republic |
| |||||||||
Ireland |
| |||||||||
Israel |
|
32. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
120MG | tablet | Discontinued | ORAL | N/A | Nov 5, 1992 |
90MG | tablet | Discontinued | ORAL | N/A | Nov 5, 1992 |
60MG | tablet | Discontinued | ORAL | N/A | Nov 5, 1992 |
30MG | tablet | Discontinued | ORAL | N/A | Nov 5, 1992 |
33. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG/ML | injectable | Prescription | INJECTION | N/A | Apr 19, 2002 |
34. TWI PHARMS
Twi Pharmaceuticals Inc has filed for 7 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Twi Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
180MG | capsule, extended release | Prescription | ORAL | AB3 | Aug 30, 2018 |
240MG | capsule, extended release | Prescription | ORAL | AB3 | Aug 30, 2018 |
300MG | capsule, extended release | Prescription | ORAL | AB3 | Aug 30, 2018 |
360MG | capsule, extended release | Prescription | ORAL | AB3 | Aug 30, 2018 |
120MG | capsule, extended release | Prescription | ORAL | AB1 | Mar 1, 2023 |
60MG | capsule, extended release | Prescription | ORAL | AB1 | Mar 1, 2023 |
90MG | capsule, extended release | Prescription | ORAL | AB1 | Mar 1, 2023 |
35. UTOPIC PHARMS
Utopic Pharmaceuticals Inc has filed for 3 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Utopic Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
120MG | capsule, extended release | Prescription | ORAL | AB2 | Aug 8, 2022 |
180MG | capsule, extended release | Prescription | ORAL | AB2 | Aug 8, 2022 |
240MG | capsule, extended release | Prescription | ORAL | AB2 | Aug 8, 2022 |
36. VALEANT PHARMS NORTH
Valeant Pharmaceuticals North America Llc has filed for 4 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Valeant Pharms North.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
120MG | capsule, extended release | Prescription | ORAL | AB3 | Dec 23, 1999 |
300MG | capsule, extended release | Prescription | ORAL | AB3 | Dec 23, 1999 |
240MG | capsule, extended release | Prescription | ORAL | AB3 | Dec 23, 1999 |
180MG | capsule, extended release | Prescription | ORAL | AB3 | Dec 23, 1999 |
37. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Diltiazem Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
120MG | capsule, extended release | Prescription | ORAL | AB4 | Aug 11, 2017 |
360MG | capsule, extended release | Prescription | ORAL | AB4 | Aug 11, 2017 |
300MG | capsule, extended release | Prescription | ORAL | AB4 | Aug 11, 2017 |
240MG | capsule, extended release | Prescription | ORAL | AB4 | Aug 11, 2017 |
180MG | capsule, extended release | Prescription | ORAL | AB4 | Aug 11, 2017 |
420MG | capsule, extended release | Prescription | ORAL | AB4 | Aug 11, 2017 |